NCT05613686 Theta Burst Stimulation for Motor Recovery
| NCT ID | NCT05613686 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Taiwan University Hospital |
| Condition | Transcranial Magnetic Stimulation |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2022-10-29 |
| Primary Completion | 2024-10-29 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2022-10-29 with a primary completion date of 2024-10-29.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive neuromodulation technology. This study will compare efficacy of different doses iTBS in combination with inhibitory rTMS on motor recovery and cortical excitability in subacute stroke patients.
Eligibility Criteria
Inclusion Criteria: * 1.Unilateral ischemic or hemorrhagic stroke * 2.Stroke within 3 months * 3.Medical Research Council Scale for Muscle Strength in upper limb ≤ 3 * 4.No previous stroke, seizure, dementia, Parkinson's disease or other degenerative neurological diseases. * 5.Patient could sit over 15 minutes * 6.Age over 20 Exclusion Criteria: * 1.Previous stroke, traumatic brain injury, brain tumor * 2.With central nervous system disease (spinal cord injury, Parkinson's disease) * 3.Any contraindication to rTMS (seizure, alcoholism, metal implant, pacemaker) * 4.Patients unable to cooperate the treatment * 5.Pregnancy * 6.Depression
Contact & Investigator
Meng Ting Lin, M.D.
PRINCIPAL INVESTIGATOR
The Department of Physical Medicine and Rehabilitation, National Taiwan University Hospital
Frequently Asked Questions
Who can join the NCT05613686 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, studying Transcranial Magnetic Stimulation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05613686 currently recruiting?
Yes, NCT05613686 is actively recruiting participants. Contact the research team at b96401093@ntu.edu.tw for enrollment information.
Where is the NCT05613686 trial being conducted?
This trial is being conducted at Taipei, Taiwan.
Who is sponsoring the NCT05613686 clinical trial?
NCT05613686 is sponsored by National Taiwan University Hospital. The principal investigator is Meng Ting Lin, M.D. at The Department of Physical Medicine and Rehabilitation, National Taiwan University Hospital. The trial plans to enroll 60 participants.